TlR2 and TlR4 are involved in the treatment of rheumatoid arthritis synovial fibroblasts with a medicated serum of asarinin through inhibition of Th1/Th17 cytokines.
Saved in:
| Title: | TlR2 and TlR4 are involved in the treatment of rheumatoid arthritis synovial fibroblasts with a medicated serum of asarinin through inhibition of T |
|---|---|
| Authors: | Dai, Qiaomei1 (AUTHOR), Li, Yaozhang1 (AUTHOR), Wang, Meiqiao1 (AUTHOR), Li, Yang2 (AUTHOR), Li, Ji3 (AUTHOR) 3078763598@qq.com |
| Source: | Experimental & Therapeutic Medicine. Apr2020, Vol. 19 Issue 4, p3009-3016. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 142475086 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: TlR2 and TlR4 are involved in the treatment of rheumatoid arthritis synovial fibroblasts with a medicated serum of asarinin through inhibition of T<subscript>h</subscript>1/T<subscript>h</subscript>17 cytokines. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Dai%2C+Qiaomei%22">Dai, Qiaomei</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Yaozhang%22">Li, Yaozhang</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Meiqiao%22">Wang, Meiqiao</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Yang%22">Li, Yang</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Ji%22">Li, Ji</searchLink><relatesTo>3</relatesTo> (AUTHOR)<i> 3078763598@qq.com</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Experimental+%26+Therapeutic+Medicine%22">Experimental & Therapeutic Medicine</searchLink>. Apr2020, Vol. 19 Issue 4, p3009-3016. 8p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=142475086 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3892/etm.2020.8557 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 8 StartPage: 3009 Titles: – TitleFull: TlR2 and TlR4 are involved in the treatment of rheumatoid arthritis synovial fibroblasts with a medicated serum of asarinin through inhibition of Th1/Th17 cytokines. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Dai, Qiaomei – PersonEntity: Name: NameFull: Li, Yaozhang – PersonEntity: Name: NameFull: Wang, Meiqiao – PersonEntity: Name: NameFull: Li, Yang – PersonEntity: Name: NameFull: Li, Ji IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: Apr2020 Type: published Y: 2020 Identifiers: – Type: issn-print Value: 17920981 Numbering: – Type: volume Value: 19 – Type: issue Value: 4 Titles: – TitleFull: Experimental & Therapeutic Medicine Type: main |
| ResultId | 1 |